- Notification that Annual Employee Plan Report will be submitted late. (NT 11-K)
30 Junio 2009 - 1:02PM
Edgar (US Regulatory)
|
UNITED
STATES
|
OMB
APPROVAL
|
|
SECURITIES AND EXCHANGE
COMMISSION
|
OMB
Number: 3235-0058
|
|
Washington, D.C.
20549
|
Expires: June
30, 2009
|
|
|
Estimated
average burden
|
|
|
hours
per response . . . . . . . 2.50
|
|
|
|
|
FORM
12b-25
|
SEC
FILE NUMBER
|
|
|
0-33505
|
|
|
|
|
NOTIFICATION OF LATE
FILING
|
CUSIP
NUMBER
|
|
|
|
(Check
one):
|
|
Form
10-K
|
|
Form
20-F
|
X
|
Form
11-K
|
|
Form
10-Q
|
|
Form
10-D
|
|
Form
N-SAR
|
|
Form
N-CSR
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For
Period Ended:
|
December 31, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transition Report on Form
10-K
|
|
|
|
|
|
|
|
|
|
|
|
|
Transition Report on Form
20-F
|
|
|
|
|
|
|
|
|
|
|
|
Transition Report on Form
11-K
|
|
|
|
|
|
|
|
|
|
|
|
Transition Report on Form
10-Q
|
|
|
|
|
|
|
|
|
|
|
|
Transition Report on Form
N-SAR
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For
the Transition Period Ended:
|
|
|
|
Read
Instruction (on back page) Before Preparing Form. Please Print or
Type
Nothing
in this form shall be construed to imply that the Commission has verified
any information contained herein.
|
If the
notification relates to a portion of the filing checked above, identify the
Item(s) to which the notification relates:
PART
I — REGISTRANT INFORMATION
Huntingdon Life Sciences, Inc. Savings and Investment
Plan
Full Name
of Registrant
Former
Name if Applicable
PO BOX 2360, METTLERS ROAD
Address
of Principal Executive Office
(Street and
Number)
EAST MILLSTONE, NEW JERSEY 08875-2360
City,
State and Zip Code
PART II — RULES
12b-25(b) AND (c)
If the
subject report could not be filed without unreasonable effort or expense and the
registrant seeks relief pursuant to Rule 12b-25(b), the following should be
completed. (Check box if appropriate)
|
(a)
|
The
reason described in reasonable detail in Part III of this form could not
be eliminated without unreasonable effort or expense
|
X
|
(b)
|
The
subject annual report, semi-annual report, transition report on Form 10-K,
Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will
be filed on or before the fifteenth calendar day following the prescribed
due date; or the subject quarterly report or transition report on Form
10-Q or subject distribution report on Form 10-D, or portion thereof, will
be filed on or before the fifth calendar day following the prescribed due
date; and
|
|
(c)
|
The
accountant's statement or other exhibit required by Rule 12b-25(c) has
been attached if applicable.
|
PART
III — NARRATIVE
State
below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR,
or the transition report or portion thereof, could not be filed within the
prescribed time period.
The
Registrant is unable to file, without unreasonable effort and expense, its Form
11-K for the period ended December 31, 2008. The Registrant has incurred a delay
in assembling the information required to be included in such
report.
(Attach
extra Sheets if Needed)
PART IV
—
OTHER INFORMATION
(1)
|
Name
and telephone number of person to contact in regard to this
notification
|
Mark Bibi
|
|
732
|
|
649-9961
|
(Name)
|
|
(Area
Code)
|
|
(Telephone
Number)
|
(2)
|
Have
all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period that
the registrant was required to file such report(s) been filed ? If answer
is no, identify report(s).
|
(3)
|
Is
it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion
thereof?
|
If so,
attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
|
Huntingdon
Life Sciences, Inc.
Savings
and Investment Plan
|
|
|
(Name
of Registrant as Specified in Charter)
|
|
has caused this notification to be
signed on its behalf by the undersigned hereunto duly
authorized.
Date
|
June
29, 2009
|
|
By
|
/s/
Mark Bibi
|
|
|
|
|
Name
Mark Bibi
|
|
|
|
|
Title
Secretary and General
Counsel
|
INSTRUCTION: The form may be signed by
an executive officer of the registrant or by any other duly authorized
representative. The name and title of the person signing the form shall be typed
or printed beneath the signature. If the statement is signed on behalf of the
registrant by an authorized representative (other than an executive officer),
evidence of the representative's authority to sign on behalf of the registrant
shall be filed with the form.
ATTENTION
Intentional
misstatements or omissions of fact constitute Federal Criminal Violations
(See 18 U.S.C. 1001).
|
GENERAL
INSTRUCTIONS
1. This
form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General Rules and
Regulations under the Securities
Exchange
Act of 1934.
2. One
signed original and four conformed copies of this form and amendments thereto
must be completed and filed with the
Securities
and Exchange Commission, Washington, D.C. 20549, in accordance with Rule 0-3 of
the General Rules and
Regulations
under the Act. The information contained in or filed with the form will be made
a matter of public record in
the
Commission files.
3. A
manually signed copy of the form and amendments thereto shall be filed with each
national securities exchange on
which
any class of securities of the registrant is registered.
4.
Amendments to the notifications must also be filed on Form 12b-25 but need not
restate information that has been
correctly
furnished. The form shall be clearly identified as an amended
notification.
5.
Electronic Filers: This form shall not be used by electronic filers unable to
timely file a report solely due to electronic
difficulties.
Filers unable to submit reports within the time period prescribed due to
difficulties in electronic filing should
comply
with either Rule 201 or Rule 202 of Regulation S-T (§232.201 or §232.202 of this
chapter) or apply for an
adjustment
in filing date pursuant to Rule 13(b) of Regulation S-T (§232.13(b) of this
chapter).
6.
Interactive data submissions. This form shall not be used by electronic filers
with respect to the submission or posting of
an
Interactive Data File (§232.11 of this chapter). Electronic filers unable to
submit or post an Interactive Data File within
the
time period prescribed should comply with either Rule 201 or 202 of Regulation
S-T (§232.201 and §232.202 of this
chapter).
Life Sciences Research (NYSE:LSR)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Life Sciences Research (NYSE:LSR)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024